# OnCo record nct06521567 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06521567/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06521567", "NCT06521567" ;
  schema:name "A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer"@en ;
  schema:alternateName "POPSTAR"@en ;
  schema:description "A phase 1/2 trial of Cobolimab, Dostarlimab in melanoma and hodgkin lymphoma, run by GlaxoSmithKline, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06521567/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06521567> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "1/2" ;
  schema:startDate "2025-03-06" ;
  onco:cancers <https://onco.cc/cancers/melanoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/dipg-dmg/>, <https://onco.cc/cancers/ependymoma/>, <https://onco.cc/cancers/osteosarcoma/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/>, <https://onco.cc/technologies/tim3-blockade/> ;
  onco:drugs <https://onco.cc/drugs/cobolimab/>, <https://onco.cc/drugs/dostarlimab/> ;
  onco:companies <https://onco.cc/companies/gsk/> .